Bairati I, Brochet F, Roy J, Gélinas M, Nabid A, Têtu B, Mâsse B, Meyer F
Groupe de recherche en épidémiologie de l'Université Laval, Québec, Canada.
Bull Cancer Radiother. 1996;83(1):12-6.
Second primary cancers often occur in head and neck cancer patients successfully treated by radiation therapy. Experimental and epidemiological data suggest that these second primaries might be prevented by antioxidant vitamins, in particular beta-carotene and alpha-tocopherol. A randomized double-blind clinical trial is being conducted in Canada to determine whether vitamin supplementation with beta-carotene (30 mg/d) and alpha-tocopherol (400 IU/d) reduces the incidence of second primaries in head and neck cancer patients treated by radiation therapy.
第二原发性癌症常发生于经放射治疗成功治愈的头颈癌患者中。实验和流行病学数据表明,这些第二原发性癌症可能可以通过抗氧化维生素来预防,尤其是β-胡萝卜素和α-生育酚。加拿大正在进行一项随机双盲临床试验,以确定补充β-胡萝卜素(30毫克/天)和α-生育酚(400国际单位/天)的维生素是否能降低接受放射治疗的头颈癌患者第二原发性癌症的发病率。